首页> EuroIntervention: journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology> Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial

Randomised comparison of a bioresorbable everolimus-eluting scaffold with a metallic everolimus-eluting stent for ischaemic heart disease caused by de novo native coronary artery lesions: the 2-year clinical outcomes of the ABSORB II trial

导出原文传递

翻译打印收藏纠错

第一作者： Chevalier, Bernard

作者： Chevalier, Bernard ^[1] ; Onuma, Yoshinobu ^[2] ; van Boven, Ad J. ^[3] ; Piek, Jan J. ^[4] ; Sabate, Manel ^[5] ; Helqvist, Steffen ^[6] ; Baumbach, Andreas ^[7] ; Smits, Pieter C. ^[8] ; Kumar, Ravindra ^[9] ; Wasungu, Luc ^[10] ; Serruys, Patrick W.

作者单位： Abbott Vasc, Diegem, Belgium ^[1] Inst Cardiovasc Paris Sud, Ramsay Gen Sante, Massy, France ^[2] Med Ctr Leeuwarden, Leeuwarden, Netherlands ^[3] Erasmus MC, Thoraxctr, Rotterdam, Netherlands ^[4] Imperial Coll, Int Ctr Cardiovasc Hlth, South Kensington Campus, London SW7 2AZ, England ^[5] Univ Copenhagen, Rigshosp, Copenhagen, Denmark ^[6] Maasstad Hosp, Dept Cardiol, Rotterdam, Netherlands ^[7] Bristol Heart Inst, Bristol, Avon, England ^[8] Acad Med Ctr, AMC Heart Ctr, Amsterdam, Netherlands ^[9] Univ Barcelona, IDIBAPS, Thorax Inst, Hosp Clin, Barcelona, Spain ^[10]

关键词 bioresorbable scaffold everolimus metallic stent randomised trial

发布时间 2017-04-06

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交